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Figure 1. Runx3 Could Improve the Utility of Smad4 as a Biomarker of Pancreatic Cancer
Biology
Patients with the combination of detectable Smad4 expression and a low level of Runx3 may benefit from
aggressive local therapy because of the proliferative nature of the tumors. In contrast, tumors with
undetectable Smad4 or a high level of Runx3 tend to be highly metastatic, and the therapeutic regime
should be tailored accordingly.surprising that positive Smad4 expression
alone has not been widely used for pre-
dictive purposes (Winter et al., 2013).
The study from Whittle et al. proposed
a potential solution of using Runx3
expression in tumor cells for predicting
the behavior of Smad4-positive tumors
(Figure 1). For clinical applications, this
idea needs to be further tested in multiple
retrospective data sets. It is also impor-
tant to understand whether the predictive
power would also apply to common com-1246 Cell 161, June 4, 2015 ª2015 Elsevier Inbinations of PDAC mutations that were
not explicitly examined in this study,
such as those involving CDKN2A. None-
theless, identifying RUNX3 as a metasta-
tic switch in this context is encouraging,
and with this knowledge, oncologists
could personalize therapeutic ap-
proaches by treating locally aggressive
tumors with higher radiation doses and/
or more liberal criteria for surgery but
prioritizing chemotherapy for those with
a metastatic potential.c.REFERENCES
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In this issue of Cell, Pelechano et al. report that sequencing of mRNA decay intermediates shows
surprisingly tight coupling of a major decay pathway to the movement of the last translating ribo-
some, revealing stress- and starvation-dependent modulation of translation elongation.Messenger RNA lives an eventful life—
each molecule is transcribed from DNA
and then may be spliced, polyadenylated,
modified, exported, transported, andtranslated before succumbing to degra-
dation. Stages in the mRNA life cycle
often overlap in important ways: splicing
acts as a co-transcriptional quality con-trol checkpoint (Chathoth et al., 2014),
mRNA-ribosome complexes are cotrans-
lationally localized to membranes by the
signal recognition particle, and mRNA is
Figure 1. Messenger RNA Has a Complex Life Cycle
Life and death of an mRNA. After decapping, co-translational 50/ 30 decay by exonucleases (red) leaves
50 ends, marking the last translating ribosome’s position.degraded co-translationally (Hu et al.,
2009). In this issue of Cell, Pelechano
et al. (2015) show that 50/ 30 degradation
of mRNA is tightly coupled to translation
to the extent that sequencing mRNA dur-
ing its destruction acts as a sensitive
readout for the translational elongation
movements of the last ribosome.
Mature mRNA has a 50 cap, which
breaks off, exposing hydroxylated (50OH)
ends, or is chewed away by the major
50 / 30 exonuclease Xrn1 and its kin,
exposing 50 monophosphorylated (50P)
ends. To quantify degradation at the
genome scale, the authors developed
methods to separately sequence each of
these three classes of mRNA ends in
budding yeast. The population of 50OH
turned out to be negligible, but 50P
mRNA sequencing—termed 5PSeq—
yielded a substantial population, about
one-eighth the size of the capped RNA
pool.
The true surprise, the authors report, is
that the positions of the ends of these 50P
molecules are not random in coding se-
quences but show pronounced three
nucleotide periodicity, mirroring the
codon-wise movement of ribosomes.
This three nucleotide pattern depends
on Xrn1 and is weakest near the startcodon, which is consistent with the
exonuclease chasing after, catching, and
then closely following the last translating
ribosome as soon as the cap is removed
(Figure 1). 5PSeq detects codon-specific
ribosome pausing in response to oxida-
tive stress, amino acid starvation, and
incorporation of amino acid analogs,
thus passing key diagnostic tests for a
measurement of translation elongation.
The apparent sensitivity of 5PSeq to
elongation dynamics is important given
recent controversy over estimates of
elongation by the widely adopted method
of ribosome profiling, which sequences
RNA fragments protected by ribosomes
from in vitro nuclease digestion. By
contrast, 5PSeq sequencesmolecules re-
sulting from in vivo degradation, omitting
a major sample-processing step, yet ap-
pears to measure ribosomal dynamics at
least as sensitively as ribosome profiling.
The two assays in fact complement each
other.
Neither 5PSeq nor ribosome profiling
directly measures ribosomal movement,
and so, although complementary, they
each carry major caveats. In the case of
5PSeq, the necessity of removing the
m7GpppG cap to expose an Xrn1-chew-
able 50P means that Xrn1 often idles whileCell 1the last ribosome traverses the early 50
mRNA region and then races to catch
up. The resulting 50P ends in this re-
gion—of unknown length—reflect a
mixture of ribosome-mediated protection
and cap-mediated protection. Which is
which? How far does cap-mediated pro-
tection extend? How much do other
mRNA features, such as base modifica-
tions and local structures, also impede
exonuclease activity? Does the last trans-
lating ribosome move like all the preced-
ing ribosomes, or do dynamics change
during the lifetime of an mRNA?
Similar concerns have swirled around
ribosome profiling, which has yielded
some dramatic claims about ribosomal
movement—prominently, the pausing of
ribosomes at Shine-Dalgarno-like se-
quences in E.coli (Li et al., 2012) and
around start codons in yeast but not at
rare codons in either organism (Qian
et al., 2012). The latter observation con-
tradicts expectations from decades of
research and has yet to be reproduced
using other methods.
By contrast, 5PSeq detects pausing of
the last ribosome at rare codons, but not
around the start codon. Instead, Pele-
chano et al. (2015) show that the elonga-
tion inhibitor cycloheximide blunts the
signals of sequence-specific pauses
while causing ribosomes to pile up near
the start codon. And, in a further contrast,
5PSeq detects an accumulation of ribo-
somes at stop codons that vanishes in
cycloheximide-treated ribosome profiling
experiments. More independent ap-
proaches are needed to distinguish the
actual from the artifactual in genome-
scale translation studies.
Recent related experimental work by
Presnyak et al. (2015) shows that codon
usage strongly modulates mRNA decay
and protein levels, with some data to sug-
gest that frequently used codons are
translated more rapidly than rare syno-
nyms. The codon-specific delays during
mRNA destruction detectable by 5PSeq
presumably relate to the elongation de-
lays, which promote that destruction, but
by what mechanism? One likely candi-
date is competition between translation
initiation complexes and the decapping
machinery. Howmight differences in ribo-
some elongation rate percolate back to
initiation or decapping? Kinetic competi-
tion between ribosomes andRNA-binding61, June 4, 2015 ª2015 Elsevier Inc. 1247
factors that recruit decapping enzymes is
one possibility; another is that slower ri-
bosomal elongation could result in a lower
rate of initiation from recycled ribosomes
reinitiating on circularized transcripts.
Mechanisms aside, these studies indi-
cate that both the onset and the physical
process of 50/ 30 decay, like other path-
ways of mRNA surveillance that occur on
the ribosome (Shoemaker and Green,
2012), are coupled to translation.
In these genome-scale studies, we
continue to see translation through a
high-throughput glass, darkly. Debates
rage about whether ribosomes pause at
some codons, or amino acids, and not
others, with seemingly minor differences
in growth conditions, sample preparation,
and statistical methods yielding incom-
patible results. Distinguishing biolog-
ical phenomena from aberrations in the
experimental glass remains challenging.
What solid ground can the translation field
stand on? Very strong signals pop out
consistently, such as ribosome pausing
at the SecM sequence in bacteria or
codon-specific pausing during amino
acid starvation (Subramaniam et al.,
2014). Weaker signals may be detectable
if amplified, such as by prolonging1248 Cell 161, June 4, 2015 ª2015 Elsevier Inpausing by deletion of release factors
(Guydosh and Green, 2014) or addition
of artificial amino acid analogs. Details of
RNA preparation, including inhibitors, 50
chemistry, nuclease digestion conditions,
and fragment length, may create or defeat
artifacts and determine detectable phe-
nomena. Which protocol details can be
safely ignored? We do not yet know.
Substantial unexplainedvariation in read
densities generated by high-throughput
sequencing makes single-gene profiles
difficult to interpret, and any individual
peak or trough might be artifactual.
Although statistical methods such as
‘‘metagene analysis’’ can reveal signals
by aggregating across the transcriptome,
any analysis pipeline might mislead and
must be validated. It is unclear whether
such methods are quantitative. Does a
2-fold increase in some model output
correspond to a 2-fold decrease in ribo-
some elongation? In particular, failing to
detect a signal with a particular high-
throughput strategy (e.g., codon-specific
pausing in ribosome profiling) does not
mean the signal is absent. The signal may
be detectable by alternative assays or
even by alternative analyses of the same
data. The arrival of 5PSeq providesc.valuable checks on the results of other
high-throughput methods.
As the serendipitous discovery of sensi-
tive last-ribosome dynamics exemplifies,
the accumulation of new and independent
methods continues to sharpen our global
picture of translation in ways that will
inspire future studies—and confidence.
REFERENCES
Chathoth, K.T., Barrass, J.D., Webb, S., and
Beggs, J.D. (2014). Mol. Cell 53, 779–790.
Guydosh, N.R., and Green, R. (2014). Cell 156,
950–962.
Hu,W., Sweet, T.J., Chamnongpol, S., Baker, K.E.,
and Coller, J. (2009). Nature 461, 225–229.
Li, G.W., Oh, E., andWeissman, J.S. (2012). Nature
484, 538–541.
Pelechano, V., Wei, W., and Steinmetz, L.M.
(2015). Cell 161, this issue, 1400–1412.
Presnyak, V., Alhusaini, N., Chen, Y.-H., Martin, S.,
Morris, N., Kline, N., Olson, S., Weinberg, D.,
Baker, K.E., Graveley, B.R., and Coller, J. (2015).
Cell 160, 1111–1124.
Qian, W., Yang, J.R., Pearson, N.M., Maclean, C.,
and Zhang, J. (2012). PLoS Genet. 8, e1002603.
Shoemaker, C.J., andGreen, R. (2012). Nat. Struct.
Mol. Biol. 19, 594–601.
Subramaniam, A.R., Zid, B.M., and O’Shea, E.K.
(2014). Cell 159, 1200–1211.Forget the Parents:
Epigenetic Reprogramming in Human Germ CellsFerdinand von Meyenn1,* and Wolf Reik1,2,3,*
1Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK
2Centre for Trophoblast Research, University of Cambridge, Cambridge CB2 3EG, UK
3Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK
*Correspondence: vonmeyenn@babraham.ac.uk (F.v.M.), wolf.reik@babraham.ac.uk (W.R.)
http://dx.doi.org/10.1016/j.cell.2015.05.039
Epigenetic reprogramming in the germline resets genomic potential and erases epigeneticmemory.
Three studies by Gkountela et al., Guo et al., and Tang et al. analyze the transcriptional and epige-
netic landscape of humanprimordial germcells, revealing a unique transcriptional network and pro-
gressive and conserved global erasure of DNA methylation.Germ cells uniquely transmit the genetic
information from one generation to the
next and give rise to the totipotent zygote
upon fertilization. While the geneticmaterial of the parents is maintained, the
epigenome undergoes extensive reprog-
ramming in primordial germ cells (PGCs),
the precursors of sperm and oocytes.Despite this pivotal role of PGCs for
development and fertility, their specifica-
tion and epigenetic reprogramming in
the human embryo remain relatively
